These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37130815)

  • 1. The role of rhFGF-2 in periodontal defect bone fill: A systematic review of the literature.
    Pouliou MM; Fragkioudakis I; Doufexi AE; Batas L
    J Periodontal Res; 2023 Aug; 58(4):733-744. PubMed ID: 37130815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periodontal surgery using rhFGF-2 with deproteinized bovine bone mineral or rhFGF-2 alone: 2-year follow-up of a randomized controlled trial.
    Aoki H; Bizenjima T; Seshima F; Sato M; Irokawa D; Yoshikawa K; Yoshida W; Imamura K; Matsugami D; Kitamura Y; Kita D; Sugito H; Tomita S; Saito A
    J Clin Periodontol; 2021 Jan; 48(1):91-99. PubMed ID: 33030228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human intrabony defect regeneration with rhFGF-2 and hyaluronic acid - a randomized controlled clinical trial.
    de Santana RB; de Santana CM
    J Clin Periodontol; 2015 Jul; 42(7):658-65. PubMed ID: 25933201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors of periodontal regeneration outcomes using rhFGF-2: A case-control study.
    Matsuda S; Ueda T; Nakashima F; Ninomiya Y; Yasuda K; Sasaki S; Hamamoto Y; Iwata T; Ouhara K; Mihara N; Kakimoto N; Mizuno N
    J Periodontal Res; 2024 Aug; 59(4):679-688. PubMed ID: 38527968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of intrabony periodontal defects using rhFGF-2 in combination with deproteinized bovine bone mineral or rhFGF-2 alone: A 6-month randomized controlled trial.
    Saito A; Bizenjima T; Takeuchi T; Suzuki E; Sato M; Yoshikawa K; Kitamura Y; Matsugami D; Aoki H; Kita D; Imamura K; Irokawa D; Seshima F; Tomita S
    J Clin Periodontol; 2019 Mar; 46(3):332-341. PubMed ID: 30758076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Chronic Periodontitis with Recombinant Human Fibroblast Growth Factor-2 and Deproteinized Bovine Bone Mineral in Wide Intrabony Defects:12-month Follow-up Case Series.
    Yoshida W; Takeuchi T; Imamura K; Seshima F; Saito A; Tomita S
    Bull Tokyo Dent Coll; 2020 Dec; 61(4):231-241. PubMed ID: 33177268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of adjunctive procedures on recombinant human fibroblast growth factor-2-mediated periodontal regeneration therapy: A retrospective study.
    Nakayama Y; Matsuda H; Itoh S; Iwai Y; Takai H; Mezawa M; Yoshino S; Ogata Y
    J Periodontol; 2021 Jul; 92(7):983-994. PubMed ID: 33128399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy of hyaluronic acid in the treatment of periodontal intrabony defect: a systematic review and meta-analysis.
    Ostos-Aguilar BI; Pinheiro Furquim C; Muniz FWMG; Faveri M; Meza-Mauricio J
    Clin Oral Investig; 2023 May; 27(5):1923-1935. PubMed ID: 36598601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year results of guided tissue regeneration in combination with deproteinized bovine bone (Bio-Oss) in the treatment of intrabony periodontal defects: a case series report.
    Stavropoulos A; Karring T
    Clin Oral Investig; 2005 Dec; 9(4):271-7. PubMed ID: 16010581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deproteinized bovine bone and gentamicin as an adjunct to GTR in the treatment of intrabony defects: a randomized controlled clinical study.
    Stavropoulos A; Karring ES; Kostopoulos L; Karring T
    J Clin Periodontol; 2003 Jun; 30(6):486-95. PubMed ID: 12795786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects. A Cochrane systematic review.
    Esposito M; Grusovin MG; Papanikolaou N; Coulthard P; Worthington HV
    Eur J Oral Implantol; 2009; 2(4):247-66. PubMed ID: 20467602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periodontal regeneration - intrabony defects: a consensus report from the AAP Regeneration Workshop.
    Reynolds MA; Kao RT; Camargo PM; Caton JG; Clem DS; Fiorellini JP; Geisinger ML; Mills MP; Nares S; Nevins ML
    J Periodontol; 2015 Feb; 86(2 Suppl):S105-7. PubMed ID: 25315019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of enamel matrix derivatives to bone substitutes for the treatment of intrabony defects: A systematic review, meta-analysis and trial sequential analysis.
    Troiano G; Laino L; Zhurakivska K; Cicciù M; Lo Muzio L; Lo Russo L
    J Clin Periodontol; 2017 Jul; 44(7):729-738. PubMed ID: 28477366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supracrestal soft tissue preservation with enamel matrix proteins in treatment of deep intrabony defects.
    Trombelli L; Bottega S; Zucchelli G
    J Clin Periodontol; 2002 May; 29(5):433-9. PubMed ID: 12060426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of regenerative treatment with rhPDGF-BB and rhFGF-2 for periodontal intra-bony defects: a systematic review and meta-analysis.
    Khoshkam V; Chan HL; Lin GH; Mailoa J; Giannobile WV; Wang HL; Oh TJ
    J Clin Periodontol; 2015 Mar; 42(3):272-80. PubMed ID: 25605424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Evaluation of the Combination of rhPDGF-BB and Xenogeneic Bone Substitutes for Treatment of Severe Periodontal Intrabony Defects: A Case Series.
    Batra C; Goel A; Daneshparvar N; Hamada Y
    Int J Periodontics Restorative Dent; 2023 Mar, Apr; 43(2):192-200. PubMed ID: 37232681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of bone replacement grafts in the treatment of periodontal osseous defects. A systematic review.
    Reynolds MA; Aichelmann-Reidy ME; Branch-Mays GL; Gunsolley JC
    Ann Periodontol; 2003 Dec; 8(1):227-65. PubMed ID: 14971256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of platelet-rich plasma, bovine porous bone mineral, and guided tissue regeneration versus platelet-rich plasma and bovine porous bone mineral in the treatment of intrabony defects: a reentry study.
    Lekovic V; Camargo PM; Weinlaender M; Vasilic N; Kenney EB
    J Periodontol; 2002 Feb; 73(2):198-205. PubMed ID: 11895286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Entire Papilla Preservation Technique with Enamel Matrix Proteins and Allogenic Bone Substitute for the Treatment of Isolated Intrabony Defects: A Prospective Case Series.
    Górski B; Kowalski J; Wyrębek B
    Int J Periodontics Restorative Dent; 2023; 43(3):387-397. PubMed ID: 37141077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periodontal Regenerative Therapy Using rhFGF-2 and Deproteinized Bovine Bone Mineral versus rhFGF-2 Alone: 4-Year Extended Follow-Up of a Randomized Controlled Trial.
    Seshima F; Bizenjima T; Aoki H; Imamura K; Kita D; Irokawa D; Matsugami D; Kitamura Y; Yamashita K; Sugito H; Tomita S; Saito A
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.